Eagle Pharmaceuticals Financials

Eagle Pharmaceuticals Stock Summary

Eagle Pharmaceuticals competes with ANI Pharmaceuticals, Phibro Animal, Prestige Brand, Collegium Pharmaceutical, and Regencell Bioscience. Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. Eagle Pharmaceuticals, Inc. was incorporated in 2007 and is headquartered in Woodcliff Lake, New Jersey. Eagle Pharmaceuticals operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 102 people.

Eagle Pharmaceuticals Key Financial Ratios

Eagle Pharmaceuticals' financial ratios allow both analysts and investors to convert raw data from Eagle Pharmaceuticals' financial statements into concise, actionable information that can be used to evaluate the performance of Eagle Pharmaceuticals over time and compare it to other companies across industries.

Eagle Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Eagle Pharmaceuticals's current stock value. Our valuation model uses many indicators to compare Eagle Pharmaceuticals value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Eagle Pharmaceuticals competition to find correlations between indicators driving Eagle Pharmaceuticals's intrinsic value. More Info.Eagle Pharmaceuticals is rated below average in return on equity category among its peers. It is one of the top stocks in return on asset category among its peers reporting about  1.36  of Return On Asset per Return On Equity. Comparative valuation analysis is a catch-all model that can be used if you cannot value Eagle Pharmaceuticals by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Eagle Pharmaceuticals' Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

Eagle Pharmaceuticals Market Pulse

Along with financial statement analysis, the daily predictive indicators of Eagle Pharmaceuticals help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Eagle Pharmaceuticals. We use our internally-developed statistical techniques to arrive at the intrinsic value of Eagle Pharmaceuticals based on widely used predictive technical indicators. In general, we focus on analyzing Eagle Pink Sheet price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Eagle Pharmaceuticals's daily price indicators and compare them against related drivers.

Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.

If you are still planning to invest in Eagle Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Eagle Pharmaceuticals' history and understand the potential risks before investing.